May 11, 2020 / 12:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the bluebird bio First Quarter 2020 Earnings Conference Call. (Operator Instructions)
I would now like to hand the conference over to Ingrid Goldberg. Thank you. Please go ahead.
Ingrid Goldberg - bluebird bio, Inc. - VP of IR
Thank you, and good morning, everyone. This is Ingrid Goldberg, Investor Relations at bluebird bio, and welcome to today's conference call to discuss our quarterly earnings and the business update. I'm joined today by several members of the bluebird management team.
The format of today's call will be opening remarks from Nick, a sickle cell disease regulatory update from Dave, and we will complete the call with highlights from our revised operating plan from Chip. We will then turn to your questions.
Before we begin, I would like to remind everyone that our discussion today includes forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on our current expectations and
Q1 2020 bluebird bio Inc Earnings Call Transcript
May 11, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers